Avail Clinical Research

SNUS Clinical Research Trials | Four Phases of Clinical Research Studies

thunderseo — Wed, 17 Mar 2010 15:17:38 +0000

Working in the field of clinical research studies is rewarding on both the scientific and humanistic side of the world. I find it a rewarding challenge to help the scientific community when we are able to advance medical achievement. But, because I am more a humanist than anything else within this world, I feel a connection to people who come to us for help with their condition, disease, or illness. In some cases, these patients are not finding the physical or mental salvation they hope to find through their current medications and or treatments. They’ve been diagnosed, but they are also hoping to not only find help for themselves but they truly want to be part of something larger. They want to help find a cure or treatment for everyone else in the same situation.

Helping convey the message that clinical research trials are safe is what my primary objective is here at Avail Clinical Research. We are here to help and do it in a way that is safe. We design our research studies to test the safety and efficacy of treatments for humans, and in order to do that clinical research studies are divided into four phases:

PHASE I TRIALS: Initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.

PHASE II TRIALS: Controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks.

PHASE III TRIALS: Expanded controlled and uncontrolled trials after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug and provide an adequate basis for physician labeling.

PHASE IV TRIALS: Post-marketing studies to delineate additional information including the drug’s risks, benefits, and optimal use.

We’ve recently been conducting clinical research trials for tobacco consumers, and we are searching for candidates who are not wanting to quit using products like SNUS, chew and dip. This is just one of the research studies we’ve been working on here in DeLand, Florida. Some of our investigational treatments have shown promising results, but there is a need to do additional research studies to test investigational methods that may help us understand your condition.

Avail Clinical Research Studies | Helping Patients

thunderseo — Tue, 16 Mar 2010 17:03:51 +0000

There are a number of great reasons to work in the field of clinical research studies, and since I’ve begun it’s been more than rewarding. Although we don’t always immediately find the ‘one-pill’ or ‘one-treatment’ we hope to find, we keep an open mind about our research studies. Each step forward either eliminates or advances our investigations — we learn what works and what doesn’t — and we pass on the information.

For me though, helping our clients understand the process of our clinical research trials is first and foremost. In many cases people come to us because they’ve been diagnosed with a condition or illness. A good portion of those clients are people who have medications and/or treatments that don’t seem to be working for them. My main job is to let clients know that our research studies are designed specifically to test the safety and efficacy of treatments for humans. The treatments may help us all understand their condition as well.

We’ve recently been conducting clinical research trials on treatment for Fibromyalgia. This is just one of the research studies we’ve been working on here in DeLand, Florida. Some of our investigational treatments have shown promising results, but there is a need to do additional research studies to test investigational methods that may help us understand your condition.

Avail Clinical Research Announces Tobacco Consumers Research Studies in DeLand, Florida

thunderseo — Wed, 10 Mar 2010 18:47:43 +0000

DeLand, Florida— March 10, 2010 — Avail Clinical Research, a privately owned research facility, founded in 1998 in DeLand, Florida, announces the launch of several tobacco consumers clinical trials to test investigational treatment options for those who use SNUS, chew, or dip and have no intention of quitting. “We are very pleased to begin the systemic evaluation of our research studies regarding tobacco consumers and their strong desires to us these types of tobacco products,” said Bruce G. Rankin, DO, CPI., the Vice Chief of Medicine at Florida Hospital DeLand. “We believe that these research studies will build significantly on the data generated by other studies conducted on tobacco consumers.” Dr. Rankin has been conducting research with Avail Clinical Research since 1999 and is currently the Medical Director.

The research studies will enroll those who are current tobacco users, and in order to participate in the studies volunteers must be users of SNUS (pronounced – ’snooze’), chew, or dip. In addition they should have the no desire to quit using either of these products.

Avail Clinical Research will provide participants with study related care, including physical examinations, laboratory services and study medications. Participants will also be compensated for time and travel. For more information regarding participation in our clinical trials, contact Avail Clinical Research at 386.310.1334, or at www.AvailClinical.com.

Avail Clinical Research Announces Psoriasis Research Studies in DeLand, Florida

thunderseo — Mon, 08 Mar 2010 16:35:14 +0000

DeLand, Florida— March 8, 2010 — Avail Clinical Research, a privately owned research facility, founded in 1998 in DeLand, Florida, announces the launch of several psoriasis clinical trials to test investigational treatment options for those already diagnosed with psoriasis. “We are very pleased to begin the systemic evaluation of our research studies to help find a viable investigational treatment solution to those suffering from psoriasis,” said Bruce G. Rankin, DO, CPI., the Vice Chief of Medicine at Florida Hospital DeLand. “We believe that these research studies will build significantly on the data generated by other studies conducted on investigational treatment options for psoriasis.” Dr. Rankin has been conducting research with Avail Clinical Research since 1999 and is currently the Medical Director.

The research studies will enroll those already diagnosed with psoriasis, which includes symptoms red patches with silvery scales, dry cracked skin that may bleed, thickened or ridged nails, and swollen and stiff joints. In order to participate in the studies volunteers must be diagnosed with psoriasis. Avail Clinical Research will not take volunteers who:

• have any evidence or treatment of malignancy within the previous 5 years,
• have a history of alcohol or substance abuse within the previous 5 years,
• have used an investigatory drug or participated in an investigatory study within 30 days of the screening,
• are pregnant, or
• are breast-feeding.

Avail Clinical Research Announces Vaccines Research Studies in DeLand, Florida

thunderseo — Fri, 05 Mar 2010 15:55:21 +0000

DeLand, Florida— March 5, 2010 — Avail Clinical Research, a privately owned research facility, founded in 1998 in DeLand, Florida, announces the launch of several vaccines clinical trials to test investigational treatment options for those already diagnosed with a specific diagnosis. “We are very pleased to begin the systemic evaluation of our vaccines research studies to help find a viable investigational treatment solution to those suffering from a specific diagnosis,” said Bruce G. Rankin, DO, CPI., the Vice Chief of Medicine at Florida Hospital DeLand. “We believe that these research studies will build significantly on the data generated by other studies conducted on investigational treatment options for your specific diagnosis.” Dr. Rankin has been conducting research with Avail Clinical Research since 1999 and is currently the Medical Director.

The vaccines research studies will enroll those already diagnosed with a specific diagnosis, which includes a multitude of symptoms from abdominal pain and bloating to chronic pain and other physical ailments. In order to participate in the studies volunteers must be diagnosed with a specific diagnosis. Avail Clinical Research will not take volunteers who:

Avail Clinical Research Announces Smoking Cessation Research Studies in DeLand, Florida

thunderseo — Thu, 04 Mar 2010 16:04:59 +0000

DeLand, Florida— March 4, 2010 — Avail Clinical Research, a privately owned research facility, founded in 1998 in DeLand, Florida, announces the launch of several smoking cessation clinical trials to test investigational treatment options for those already diagnosed with a nicotine addiction. “We are very pleased to begin the systemic evaluation of our smoking cessation research studies to help find a viable investigational treatment solution to those suffering from nicotine addiction,” said Bruce G. Rankin, DO, CPI., the Vice Chief of Medicine at Florida Hospital DeLand. “We believe that these research studies will build significantly on the data generated by other studies conducted on investigational treatment options for nicotine addiction.” Dr. Rankin has been conducting research with Avail Clinical Research since 1999 and is currently the Medical Director.

The smoking cessation research studies will enroll those already diagnosed with nicotine addiction, which includes symptoms like intense cravings for a cigarette when stressed, and anxiety, agitation, headaches, and nausea when without a cigarette for more than thirty minutes. In order to participate in the studies volunteers must be diagnosed with nicotine addiction. Avail Clinical Research will not take volunteers who:

Avail Clinical Research Announces Rheumatoid Arthritis Research Studies in DeLand, Florida

thunderseo — Wed, 03 Mar 2010 16:07:32 +0000

DeLand, Florida— March 3, 2010 — Avail Clinical Research, a privately owned research facility, founded in 1998 in DeLand, FL, announces the launch of several rheumatoid arthritis clinical trials to test investigational treatment options for those already diagnosed with rheumatoid arthritis. “We are very pleased to begin the systemic evaluation of our research studies to help find a viable investigational treatment solution to those suffering from rheumatoid arthritis,” said Bruce G. Rankin, DO, CPI., the Vice Chief of Medicine at Florida Hospital DeLand. “We believe that these research studies will build significantly on the data generated by other studies conducted on investigational treatment options for rheumatoid arthritis.” Dr. Rankin has been conducting research with Avail Clinical Research since 1999 and is currently the Medical Director.

The research studies will enroll those already diagnosed with rheumatoid arthritis, which includes symptoms like joint pain, tenderness and swelling, firm bumps of tissue under the skin on your arms, fatigue, and morning stiffness that lasts for hours. In order to participate in the studies volunteers must be diagnosed with rheumatoid arthritis. Avail Clinical Research will not take volunteers who:

Avail Clinical Research Announces Restless Leg Syndrome Research Studies in DeLand, Florida

thunderseo — Tue, 02 Mar 2010 16:12:34 +0000

DeLand, Florida— March 2, 2010 — Avail Clinical Research, a privately owned research facility, founded in 1998 in DeLand, Florida, announces the launch of several restless leg syndrome clinical trials to test investigational treatment options for those already diagnosed with restless leg syndrome (RLS). “We are very pleased to begin the systemic evaluation of our research studies to help find a viable investigational treatment solution to those suffering from restless leg syndrome,” said Bruce G. Rankin, DO, CPI., the Vice Chief of Medicine at Florida Hospital DeLand. “We believe that these research studies will build significantly on the data generated by other studies conducted on investigational treatment options for RLS.” Dr. Rankin has been conducting research with Avail Clinical Research since 1999 and is currently the Medical Director.

The research studies will enroll those already diagnosed with restless leg syndrome, which includes symptoms in your calves, thighs, and feet that are often expressed as crawling, tingling, cramping, pulling, painful, tugging, gnawing and burning. They typically begin after laying down or sitting for an extended period and lessens as you move. In order to participate in the studies volunteers must be diagnosed with restless leg syndrome. Avail Clinical Research will not take volunteers who:

Avail Clinical Research Announces Overactive Bladder Research Studies in DeLand, Florida

thunderseo — Mon, 01 Mar 2010 17:42:10 +0000

DeLand, Florida— March 1 2010 — Avail Clinical Research, a privately owned research facility, founded in 1998 in DeLand, Florida, announces the launch of several overactive bladder clinical trials to test investigational treatment options for those already diagnosed with an overactive bladder. “We are very pleased to begin the systemic evaluation of our research studies to help find a viable investigational treatment solution to those suffering from an overactive bladder,” said Bruce G. Rankin, DO, CPI., the Vice Chief of Medicine at Florida Hospital DeLand. “We believe that these research studies will build significantly on the data generated by other studies conducted on investigational treatment options for overactive bladder.” Dr. Rankin has been conducting research with Avail Clinical Research since 1999 and is currently the Medical Director.

The research studies will enroll those already diagnosed with an overactive bladder, which includes symptoms like strong and sudden urges to urinate, involuntary loss of urine immediately following the urgent need to urinate, urinate eight or more times in 24 hours, and awaken two or more times a night to urinate. In order to participate in the studies volunteers must be diagnosed with an overactive bladder. Avail Clinical Research will not take volunteers who:

Avail Clinical Research Announces Osteoarthritis Research Studies in DeLand, Florida

thunderseo — Fri, 26 Feb 2010 15:58:01 +0000

DeLand, Florida— February 26, 2010 — Avail Clinical Research, a privately owned research facility, founded in 1998 in DeLand, Florida, announces the launch of several osteoarthritis clinical trials to test investigational treatment options for those already diagnosed with osteoarthritis (OA). “We are very pleased to begin the systemic evaluation of our research studies to help find a viable investigational treatment solution to those suffering from osteoarthritis,” said Bruce G. Rankin, DO, CPI., the Vice Chief of Medicine at Florida Hospital DeLand. “We believe that these research studies will build significantly on the data generated by other studies conducted on investigational treatment options for O.A.” Dr. Rankin has been conducting research with Avail Clinical Research since 1999 and is currently the Medical Director.

The research studies will enroll those already diagnosed with osteoarthritis, which includes symptoms like pain in the hands, hips, knees or feet, stiffness for more than an hour, tenderness and occasional swelling, and joint deformity. In order to participate in the studies volunteers must be diagnosed with osteoarthritis. Avail Clinical Research will not take volunteers who:

Avail Clinical Research will provide participants with study related care, including physical examinations, laboratory services and study medications. Participants will also be compensated for time and travel. For more information regarding participation in our our clinical trials, contact Avail Clinical Research at 386.310.1334, or at www.AvailClinical.com.